Leon Kaulen
@kaulenleon.bsky.social
Neurologist @uniklinik_hd | Clinician Scientist @HdNeurooncology @DKFZ, @MGHNeuroOnc | Interested in CNS lymphomas and development of personalized therapies
Full text link: ashpublications.org/blood/articl.... Grateful to everyone involved in this work.
@neurooncologyhd.bsky.social @cancerneuroscience.bsky.social @eanoassociation.bsky.social @neuroonc.bsky.social @ash.hematology.org @wickwolfgang.bsky.social
@neurooncologyhd.bsky.social @cancerneuroscience.bsky.social @eanoassociation.bsky.social @neuroonc.bsky.social @ash.hematology.org @wickwolfgang.bsky.social
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell Therapy
Key Points. Larger CNS lymphoma tumor volume at baseline predicted TIAN occurrence after CD19-CAR T-cell therapyTIAN correlated with improved overall respo
ashpublications.org
July 21, 2025 at 10:56 AM
Full text link: ashpublications.org/blood/articl.... Grateful to everyone involved in this work.
@neurooncologyhd.bsky.social @cancerneuroscience.bsky.social @eanoassociation.bsky.social @neuroonc.bsky.social @ash.hematology.org @wickwolfgang.bsky.social
@neurooncologyhd.bsky.social @cancerneuroscience.bsky.social @eanoassociation.bsky.social @neuroonc.bsky.social @ash.hematology.org @wickwolfgang.bsky.social